PlaqueTec identifies endotype-specific biomarkers to advance precision medicine for CAD
PlaqueTec has raised €12M across 2 funding rounds from 3 investors, most recently a round in Apr 2026. Based in Cambridge, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: too soon vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2026-04-28 | Other | €4.3M | — | View deal → |
| 2024-04-30 | Other | €7.5M | Existing investors,Future Fund,Lord Moynihan of Chelsea | View deal → |
